Susumu Takeuchi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Liquid Chromatography

Artificial Intelligence

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Cancer medicine

Japanese journal of clinical oncology

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuhiro Kato, Masaru Matsumoto, Natsuki Takano, Mariko Hirao, Kuniko Matsuda, Takehiro Tozuka, Naomi Onda, Shinji Nakamichi, Susumu Takeuchi, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway. Cancer medicine 13 (12) (2024)
Yasuhiro Kato, Masaru Matsumoto, Natsuki Takano, Mariko Hirao, Kuniko Matsuda, Takehiro Tozuka, Naomi Onda, Shinji Nakamichi, Susumu Takeuchi, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway. Cancer medicine 13 (12) (2024)
Susumu Takeuchi, Akinobu Yoshimura, Atsushi Sofuni, Yuri Ueda, Tomohiro Umezu, Masahiko Kuroda, Aoi Sukeda, Jun Matsubayashi, Toshitaka Nagao, Masato Bingo, Natsuko Inagaki, Tatsuo Ohira, Masahiro Seike, Norihiko Ikeda
A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancers. Japanese journal of clinical oncology (2024)
Yasuhiro Kato, Masaru Matsumoto, Natsuki Takano, Mariko Hirao, Kuniko Matsuda, Takehiro Tozuka, Naomi Onda, Shinji Nakamichi, Susumu Takeuchi, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway. Cancer medicine 13 (12) (2024)
Susumu Takeuchi, Kaoru Kubota, Shunichi Sugawara, Satoshi Teramukai, Rintaro Noro, Kei Fujikawa, Takashi Hirose, Shinji Atagi, Seigo Minami, Shinichiro Iida, Hiroshi Kuraishi, Tomoiki Aiba, Yuji Minegishi, Masaru Matsumoto, Masahiro Seike, Akihiko Gemma, Masaaki Kawahara, null null
Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer: A randomized phase II trial (JMTO LC14-01). Cancer medicine (2023)
Takehiro Tozuka, Rintaro Noro, Akihiko Miyanaga, Shinji Nakamichi, Susumu Takeuchi, Masaru Matsumoto, Kaoru Kubota, Kazuo Kasahara, Masahiro Seike
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancer. Cancer medicine (2023)
Yujin Kudo, Yoshihisa Shimada, Jun Matsubayashi, Yoshiro Kitamura, Yojiro Makino, Sachio Maehara, Masaru Hagiwara, Jinho Park, Takafumi Yamada, Susumu Takeuchi, Masatoshi Kakihana, Toshitaka Nagao, Tatsuo Ohira, Jun Masumoto, Norihiko Ikeda
Artificial intelligence analysis of three-dimensional imaging data derives factors associated with postoperative recurrence in patients with radiologically solid-predominant small-sized lung cancers. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 61 (4) (2022)